Bruker Corporation (BRKR) vs Penumbra, Inc. (PEN)
Bruker Corporation and Penumbra, Inc. are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.6B against $9.7B — 1.3× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Penumbra, Inc. trades at 78.0×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.6% against 1.65%. Penumbra, Inc. has the higher net margin (10.7% vs −3.05%) and the higher return on invested capital (13.1% vs −0.47%). Across the 20 metrics below, Penumbra, Inc. leads on 16 and Bruker Corporation on 4.
Valuation
Profitability
| Metric | BRKR | PEN | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.42% | 67.84% | 56.01% |
| Operating margin | (0.87%) | 12.45% | (15.03%) |
| Net margin | (3.05%) | 10.67% | (20.40%) |
| Free cash flow margin | 2.68% | 14.35% | (7.24%) |
| Return on equity | (5.07%) | 11.37% | (15.32%) |
| Return on assets | (1.73%) | 8.80% | (19.72%) |
| Return on invested capital | (0.47%) | 13.13% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack